期刊文献+

新型顺铂纳米微球的制备及性质研究 被引量:1

Novel nanoparticles of cisplatin:Preparation and study of properties
下载PDF
导出
摘要 目的:采用自行合成的高分子载体,制备负载顺铂的纳米微球,全面考察其性质。方法:通过开环聚合法,制备单甲氧基聚乙二醇-聚己内酯(mPEG-PCL)两嵌段聚合物以及末端带有羟基的PCL作为载体,采用优化的w/o/w双乳化扩散/挥发法,制备负载顺铂的纳米微球。考察载体的结构、分子量、纳米微球的形态、粒径分布、稳定性、生物相容性等性质。结果:通过开环聚合法合成mPEG-PCL两嵌段聚合物以及末端带有羟基的PCL,测定分子量和设计分子量相近。通过双乳剂法制备的空白粒子平均粒径为326.9±5.4nm,载药粒子在冻干前后的粒径分别为339.1±4.9及370.3±2.5nm。粒子呈规整的球形,在水溶液中稳定。顺铂的载药效率为77.4%,载药量为4.72%。体外释放实验显示,载药粒子具有缓释特征,在6h、24h、48h分别释放53%、75%、93%。载体在高浓度时对细胞生长无抑制作用,毒性低。结论:研究表明这种新型载药系统具有良好的应用价值。 Objective:to prepare cisplatin- loaded nanoparticles with bi -block copolymer mPEG -PCL and PCL, and evaluate their properties. Methods : mPEG - PCL and HO - PCL were synthesized by ring - opening poly- merization method and the nanoparticles were prepared by developed w/o/w double emulsion method. The structure and molecular weight of the polymers, the morphology of the nanoparticles, as well as their stability and biocompatibility were studied. Results: mPEG - PCL and PCL were synthesized with desired molecular weight. The diameter of blank nanopaticles was 326.9 ± 5.4nm, and the diameters of cisplatin - loaded nanoparticles before and after freeze dry were 339.1 ± 4.9 and 370.3 ± 2.5nm, respectively. The encapsulation efficiency and drug loading content were 77.4% and 4.72% respectively. The in vitro release presented a sustain - release pattern. The blank nanoparticles were non - toxic to the Lo2 cell line. Conclusion: The above findings indicate the potential of this nanoparticles as carrier for cisplatin.
出处 《现代肿瘤医学》 CAS 2010年第1期1-4,共4页 Journal of Modern Oncology
基金 国家自然科学基金项目(编号:30872471) 江苏省研究生创新基金项目(编号:CX08B-167Z)
关键词 顺铂 纳米粒子 双乳剂法 药物输送体系 抗肿瘤 cisplatin nanoparticles w/o/w double - emulsion method drug - delivery system antitumor
  • 相关文献

参考文献13

  • 1Dennis A Casciato. Manual of chnical oncology [ M ]. Philadelphia: Lippincott Williams&Wilkins ,2004:56.
  • 2Li H, Wang C, Wen Y, et al. Treatment of squamous cell carcinoma of the tongue using arterial embolism with cisplatin - loaded albumin microspheres:a microstructural and ultrastructural investigation [J]. Chin J Dent Res,1999,2:61 -66.
  • 3Newman MS, Colbern GT, Working PK, et al. Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long- circulating,pegylated liposomes (SPI- 077 ) in tumor - bearing mice [ J ]. Cancer Chemother Pharmacol, 1999,43 : 1 -7.
  • 4Kumagai S, Sugiyama T, Nishida T, et al. Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin - containing microspheres [ J ]. Jpn J Cancer Res, 1996,87:412 - 417.
  • 5Hu Y, Jiang X, Ding Y, et al. Preparation and drug release behaviors of nimodipine - loaded poly (caprolactone) - poly ( ethylene oxide) - polylactide amphiphilic copolymer nanoparticles [ J ]. Biomaterials,2003,24:2395 - 2404.
  • 6Kim JH, Bae YH. Albumin loaded microsphere of amphiphilic poly (ethylene glycol)/poly(alpha -ester) muhiblock copolymer[ J]. Eur J Pharm Sci,2004,23:245 -251.
  • 7Gryparis EC, Hatziapostolou M, Papadimitriou E, et al. Anticancer activity of cisplatin - loaded PLGA - mFEG nanoparticles on LNCaP prostate cancer cells [ J ]. Eur J Pharm Biopharm,2007,67 : 1 -8.
  • 8Graves RA, Pamujula S, Moiseyev R, et al. Effect of different ratios of high and low molecular weight PLGA blend on the characteristics of pentamidine microcapsules [ J]. Int J Pharm, 2004,270 : 251 - 262.
  • 9M Yokoyama, T Okano, Y Sakurai, et al. Introduction of cisplatin into polymeric micelle[ J]. ] Control Release ,1996,39:351 - 356.
  • 10Avgoustakis K, Beletsi A, Panagi Z, et al. PLGA - mPEG nanopartides of cisplatin : in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties [ J]. J Control Release ,2002,79 : 123 - 135.

二级参考文献11

  • 1Silva Cunha A., Cheron M., Grossiord J. L. et al. Int. J. Pharm.[J], 1998, 169: 33-44.
  • 2Kawashima Y., Yamamoto H., Takeuchi H. et al. J. Controlled Release.[J], 1999, 62: 279-287.
  • 3Carino G. P., Jacob J. S., Mathiowitz E. J. Controlled Release[J], 2000, 65: 261-269.
  • 4Zentner G. M., Rathi R., Shih C. et al. J. Controlled Release[J], 2001, 72: 203-215.
  • 5Rosa G. D., Iommelli R., La Rotonda M. I. et al. J. Controlled Release[J], 2000, 69: 283-295.
  • 6Yamaguchi Y., Takenaga M., Kitagawa A. et al. J. Controlled Release[J], 2002, 81: 235-249.
  • 7Pekarek K. J., Jacob J. S., Mathiowitz E. Nature[J], 1994, 367: 258-260.
  • 8Matsumoto A., Matsukawa Y., Suzuki T. et al. J. Controlled Release[J], 1997, 48: 19-27.
  • 9高长有,袁峻,管建均,沈家骢.明胶在聚氨酯表面的固定化及其对内皮细胞生长的促进作用[J].高等学校化学学报,2002,23(6):1210-1212. 被引量:16
  • 10朴龙海,张昕照,陈学思,邓明霄,姜连升,景遐斌.有机氨钙催化聚合脂肪族环酯[J].高等学校化学学报,2003,24(2):346-349. 被引量:6

共引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部